ELI LILLY I4V-MC-JADV

By June 19, 2019 Closed

“A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy”

Join the discussion 6 Comments

Leave a Reply